PTC Therapeutics News and Activities
Presence
PTC Therapeutics develops medicines for rare diseases and related conditions. Its products and services include prescription therapies and drug research for patients, healthcare providers, and specialty care partners.
PTC Therapeutics products and services overview:
- Rare disease therapies
- Genetic medicines
- Prescription drugs
- Drug development
- Research services
Revenue: ~$940 million
Employees: 950
Headquarters: Warren, United States (USA)
PTC Therapeutics is one of the...
PTC Therapeutics is a company listed under the stock ticker PTCT (US).
PTC Therapeutics has a direct presence in 2 countries.
Executives
View the org chart displaying its 29 main executives
Most searched biographies at PTC Therapeutics
- Matthew Klein, Chief Executive Officer and Director
- Glenn Steele, Director
- David Southwell, Member of the Board
Popular executive movements at PTC Therapeutics
- Jessica Chutter has joined the company as Director (posted on March 25 2026).
Create your alert
to follow the executive moves at PTC Therapeutics.
Pharmaceuticals
PTC Therapeutics has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by PTC Therapeutics
- PTC Therapeutics and AADC Family Network Announce First-Ever AADC Deficiency Awareness Day in Massachusetts | PTC Therapeutics, Inc.
- Evrysdi™ (risdiplam) Continues to Make Global Progress for the Treatment of Spinal Muscular Atrophy | PTC Therapeutics, Inc.
- PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2020 Financial Results | PTC Therapeutics, Inc.
- RSS News Feeds | PTC Therapeutics, Inc.
- Two-Year Data of Evrysdi™ (risdiplam) in Infants with Spinal Muscular Atrophy Demonstrate Continued Improvement of Developmental Milestones | PTC Therapeutics, Inc.
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PTC Therapeutics, Inc.
- PTC Therapeutics to Present at the Jefferies Virtual Gene Therapy/Editing Summit | PTC Therapeutics, Inc.
- PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for Individuals Suspected of Having Neurotransmitter Disorders | PTC Therapeutics, Inc.PTC TherapeuticsPTC Therapeutics
- PTC Therapeutics' 2020 STRIVE Awards for Duchenne Muscular Dystrophy Recognize Four Patient Advocacy Organizations | PTC Therapeutics, Inc.PTC TherapeuticsPTC Therapeutics
- PTC Therapeutics to Present at the Cantor Virtual Global Healthcare Conference | PTC Therapeutics, Inc.PTC TherapeuticsPTC Therapeutics
- View more press releases Close
Social media about PTC Therapeutics
- PTC Therapeutics on Wikipedia, Google News & Yahoo Finance
- PTC Therapeutics on LinkedIn, X (Twitter) & YouTube
